Eczema Free Forever™ Eczema Free Forever™

Sanofi and Regeneron encounter more payer resistance over new … – STAT


STAT
Sanofi and Regeneron encounter more payer resistance over new …
STAT
Once again, Sanofi and Regeneron Pharmaceuticals are running into roadblocks trying to win over payers with their new drug for severe eczema. This time a U.K. government watchdog decided the drug would not be cost effective.
Sanofi makes double EU filing for cancer and asthma drugspharmaphorum
Sanofi responds to draft NICE guidance for its innovative atopic dermatitis drug Dupixent® ? (dupilumab)[i]PharmiWeb.com (press release)
Regeneron And Sanofi Say EMA Accepts For Review Application For DUPIXENNasdaq
PharmaTimes
all 21 news articles »

eczema – Google News

Sanofi and Regeneron encounter more payer resistance over new eczema drug — this time, in the UK – STAT


STAT
Sanofi and Regeneron encounter more payer resistance over new eczema drug — this time, in the UK
STAT
nce again, Sanofi (SNY 1) and Regeneron Pharmaceuticals (REGN 2) are running into roadblocks trying to win over payers with their new drug for severe eczema. The latest frustration is occurring in the U.K., where a government watchdog decided the drug
Sanofi makes double EU filing for cancer and asthma drugspharmaphorum
Sanofi responds to draft NICE guidance for its innovative atopic dermatitis drug Dupixent® ? (dupilumab)[i]PharmiWeb.com (press release)
Regeneron And Sanofi Say EMA Accepts For Review Application For DUPIXENNasdaq
PharmaTimes
all 17 news articles »

eczema – Google News

Heart disease and mental health conditions more prevalent in psoriasis

Moderate-to-severe psoriasis and psoriatic arthritis patients are more likely than people without these conditions to have cardiovascular and mental comorbidities, as well as higher healthcare utilization and medical costs, primarily from pharmacy-related expenses, according to a recent retrospective study of U.S. Department of Defense patients.
Dermatology Times – Dermatology

Skin lupus can progress more rapidly than previously thought

Systemic disease among patients with discoid lupus erythematosus, a chronic form of cutaneous lupus, can develop within one to two years of initial diagnosis, says Joseph F. Merola, M.D., reporting at the American Academy of Dermatology annual meeting in San Diego.
Modern medicine – dermatology

Black children may suffer more severe eczema, but are less likely to receive treatment, study shows – Chicago Tribune


Chicago Tribune
Black children may suffer more severe eczema, but are less likely to receive treatment, study shows
Chicago Tribune
Black children may have more severe eczema than white children, but they are less likely to visit a doctor for this common inflammatory skin condition, new research shows. Eczema causes the skin to become red and itchy. Roughly 11 percent of children

eczema – Google News

Black children may suffer more severe eczema, but are less likely to receive treatment, study shows – Chicago Tribune


Chicago Tribune
Black children may suffer more severe eczema, but are less likely to receive treatment, study shows
Chicago Tribune
Black children may have more severe eczema than white children, but they are less likely to visit a doctor for this common inflammatory skin condition, new research shows. Eczema causes the skin to become red and itchy. Roughly 11 percent of children

eczema – Google News

Black children may suffer more severe eczema, but are less likely to receive treatment, study shows – Chicago Tribune


Chicago Tribune
Black children may suffer more severe eczema, but are less likely to receive treatment, study shows
Chicago Tribune
Black children may have more severe eczema than white children, but they are less likely to visit a doctor for this common inflammatory skin condition, new research shows. Eczema causes the skin to become red and itchy. Roughly 11 percent of children

eczema – Google News